FMGE 2023 Classes at Top Residential Coaching Centre

FMGE 2023 Classes at Top Residential Coaching Centre

FMGE 2023 Classes at Top Residential Coaching Centre


           Obstetrics and Gynecology

                 Topic: Endometrial Cancer

 Kings International Medical Academy offers top-notch FMGE coaching and appoints eminent doctors from India to act as faculty members for our students. One of our esteemed educators, Dr. Vidhya, delivers captivating lectures on Obstetrics and Gynecology, providing our students with a thorough understanding of the subject. Today, we will delve into the topic of Endometrial Cancer and explore it comprehensively.

                  ENDOMETRIAL CANCER

Premalignant lesion: Endometrial hyperplasia
MC Sx: Post menopausal bleeding (PMB)
MCC for SX: Endometrial atrophy 60%(senile endometriosis)
*TAMOXIFEN cause endometrial CA
MC HNPCC (lynch2) cancer in femals: Endometrial CA (60%)
SPORADIC CA - 90% FAMILIAL CA: 10%

I CONFINED TO UTERUS
IA <50% myo (No adjuvant Tx need) FOLLOW UP
IB >50% myometrium Adjuvant CHEMO + RADIO
II CERVICAL INVOLVEMENT
IIA Endocervical glandular involve
IIB Cervical stromal invasion
III Peritoneum and Nodes
IIIA +ve peritoneal cytology / uterine serosa invasion or adnexal involve
IIIB VAGINA / Parametrium involve
IIIC C1: Pelvic LN C2: Para aortic LN
IV
IVA Bladder / Bowel involved
IVB Distant metastasis Adj CHEMO
Dx: Staging Laparotomy: Midline vertical incision --> Inspect organs Ascites - take cytology (if no ascites-> saline - peritoneal wash) TOTAL ABD HYSTERECTOMY + B/L SalphingoOophorectomy Metastasis >1cm - remove Intracolic omentectomy --> biopsy Lymph nodes (pelvic+paraaortic) - remove

Types of Endometrial Hyperplasia: (Premalignant lesions)

Malig risk
Simple w/o atypia 1% Progesterone therapy
Complex w/o atypia 3%
Simple with atypia 8% Hyterectomy
Complex with atypia 29%

Endometrial cancer:

Type 1 Type 2
(ENDOMETRIOID) 80% (Non-endometrioid)20%
WHITE woman
Estrogen dependent (+)
Pre-existing lesion (+)
Good prognosis (+)
PERI menopause
KRAS, BRAF mutation
MCType:ADENOCARCINOMA
BLACK women
(-)
(-)
(-)
POST Menopause
P53 mutation (high grade)
Others: SQUAMOUS, serous, mucinous, clear cell, mixed, undifferentiated/unclassified